GenMont Biotech Inc
TWSE:3164
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
GenMont Biotech Inc
GenMont Biotech Inc
Net Income (Common)
GenMont Biotech Inc
Net Income (Common) Peer Comparison
4142
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
GenMont Biotech Inc
TWSE:3164
|
Net Income (Common)
NT$59.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
40%
|
|
|
Adimmune Corp
TWSE:4142
|
Net Income (Common)
-NT$574.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
Net Income (Common)
-NT$265.7m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
See Also
What is GenMont Biotech Inc's Net Income (Common)?
Net Income (Common)
59.5m
TWD
Based on the financial report for Mar 31, 2024, GenMont Biotech Inc's Net Income (Common) amounts to 59.5m TWD.
What is GenMont Biotech Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
40%
Over the last year, the Net Income (Common) growth was 42%. The average annual Net Income (Common) growth rates for GenMont Biotech Inc have been -10% over the past three years , -21% over the past five years , and 40% over the past ten years .
You don't have any saved screeners yet
